European biotech Archives -

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund –

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

https://pharmaphorum.com/news/kyowa-kirin-backs-e125m-life-science-fund-closed-by-fountain-healthcare/

News/ News/ R&D

BMS backs record $600m European venture fund closed by LSP

Phil Taylor European biotech, investment, Life Sciences, venture capital 0 Comment

Venture capital group Life Science Partners has closed its sixth investment round, raising a record $600 million that

BMS backs record $600m European venture fund closed by LSP

https://pharmaphorum.com/news/bms-backs-record-600m-european-venture-fund-closed-by-lsp/

Market Access/ News/ News/ R&D/ UK & Europe

Acacia Pharma stock market launch to support nausea products

Andrew McConaghie Acacia Pharma, European biotech, UK biotech 0 Comment

Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange

Acacia Pharma stock market launch to support nausea products

https://pharmaphorum.com/news/acacia-pharma-stock-market-launch-support-nausea-product-launch/

News/ News/ R&D/ R&D/ UK & Europe

Sanofi steals in to buy Ablynx for €3.9 billion

Andrew McConaghie Ablynx, European biotech, M&A, Mergers and acquisitions, Sanofi 0 Comment

Sanofi has leapt in to buy Ablynx for €3.9 billion ($4.85bn) outbidding an offer from Novo Nordisk which

Sanofi steals in to buy Ablynx for €3.9 billion

https://pharmaphorum.com/news/sanofi-steals-buy-ablynx-e3-9-billion/

News/ News/ R&D/ R&D/ UK & Europe

Google invests in UK vaccine pioneer Vaccitech

Andrew McConaghie European biotech, Google, Google Ventures, UK biotech, Vaccitech 0 Comment

Google has invested £20 million ($27.1m) in a biotech firm spun out of Oxford University working on novel

Google invests in UK vaccine pioneer Vaccitech

https://pharmaphorum.com/news/google-invests-vaccitech/

M&A/ News/ R&D/ UK & Europe

Takeda to buy stem cell specialists TiGenix for $626m

Richard Staines European biotech, gastroenterology, M&A, Takeda, TiGenix 0 Comment

Decision follows EU regulators’ decision to back Crohn’s stem cell therapy

Takeda to buy stem cell specialists TiGenix for $626m

https://pharmaphorum.com/news/takeda-buy-gastro-biotech-tigenix-463m/

News/ UK & Europe

Boehringer collaborates with Autifony on schizophrenia drug

Richard Staines Autifony, Boehringer Ingelheim, European biotech, R&D, schizophrenia, UK biotech 0 Comment

Deal could be worth 627.5 million euros

Boehringer collaborates with Autifony on schizophrenia drug

https://pharmaphorum.com/news/boehringer-collaborates-autifony-schizophrenia-drug/

News/ R&D/ UK & Europe

Gilead could make a move for Galapagos within weeks

Andrew McConaghie European biotech, Galapagos, Gilead 0 Comment

The share price of Belgium-Dutch biotech Galapagos is rising thanks to renewed speculation that Gilead may be poised

Gilead could make a move for Galapagos within weeks

https://pharmaphorum.com/news/gilead-make-move-galapagos-within-weeks/

News/ R&D/ Top stories/ US

After more encouraging data, Ablynx to file first drug with FDA

Richard Staines Ablynx, aTTP, Biotech, European biotech, Rare diseases 0 Comment

New trial data will be included in US and EU filings

After more encouraging data, Ablynx to file first drug with FDA

https://pharmaphorum.com/news/ablynx-prepares-us-filing-caplacizumab-attp/

Trending

European biotech

Login